PPARG and urothelial carcinoma: Some studies have suggested that PPARG-dependent transcriptional regulation may be involved in the etiology of urothelial carcinoma [37], and decreasing PPARG activity via drug inhibition or gene ablation inhibits the proliferation of BC cells [38].